Effects of probiotics on atopic dermatitis: A randomised controlled trial

Archives of Disease in Childhood

Volumn 90, Issue 9, 2005, Pages 892-897

  Weston, S ^a   Halbert, A ^b   Richmond, P ^a   Prescott, S L ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ARTICLE; ATOPIC DERMATITIS; AUSTRALIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INFANT; LACTOBACILLUS FERMENTUM; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANTI-ALLERGIC AGENTS; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LACTOBACILLUS; MALE; PROBIOTICS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 20444475470     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2004.060673     Document Type: Article

References (25)

1. Anonymous. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351(9111):1225-32.
2. Wadonda-Kabondo N, Sterne JAC, Golding J, et al. A prospective study of the prevalence and incidence of atopic dermatitis in children aged O-42 months. Br J Dermatol 2003;149(5):1023-8.
3. Eichenfield LF, Hanifin JM, Beck LA, et al. Atopic dermatitis and asthma: parallels in the evolution of treatment. Pediatrics 2003;111(3):608-16.
4. Kemp AS. Cost of illness of atopic dermatitis in children: a societal perspective. Pharmacoeconomics 2003;21(2):105-13.
5. Emerson R, Williams H, Allen B. What is the cost of atopic dermatitis in preschool children? Br J Dermatol 2001;143:514-22.
6. Isolauri E, Arvola T, Sutas Y, et al. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000;30:1604-10.
7. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997;99:179-85.
8. Rosenfeldt V, Benfeldt E, Nielsen S, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003;111(2):389-95.
9. Heller F, Duchmann R. Intestinal flora and mucosal immune responses. Int J Med Microbiol 2003;293(1):77-86.
10. Neaville WA, Tisler C, Bhattacharya A, et al. Developmental cytokine response profiles and the clinical and immunologic expression of atopy during the first year of life. J Allergy Clin Immunol 2003;112(4):740-6.
11. Lammers KM, Brigidi P, Vitali B, et al. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 2003;38(2):165-72.
12. Sudo N, Sawamura S, Tanaka K, et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997;159:1739-45.
13. Ball T, Castro-Rodriguez J, Griffith K, et al. Siblings, day-care attendance and the risk of asthma and wheezing during childhood. N Engl J Med 2000;343:538-43.
14. Kilpi T, Kero J, Jokinen J, et al. Common respiratory infections early in life may reduce the risk of atopic dermatitis. Clin Infect Dis 2002;34:620-6.
15. Sherriff A, Golding J. Hygiene levels in a contemporary population cohort are associated with wheezing and atopic eczema in preschool infants. Arch Dis Child 2002;87(1):26-9.
16. Matricardi PM, Bjorksten B, Bonini S, et al. Microbial products in allergy prevention and therapy. Allergy 2003;58(6):461-71.
17. Bottcher M, Nordin E, Sandin A, et al. Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy 2000;30(11):1590-6.
18. von Mutius E, Braun-Fahrlander C, Schierl R, et al. Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy 2000;30(9):1230-4.
19. Anonymous. Severity Scoring of Atopic Dermatitis: the SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186(1):23-31.
20. Hanafin J, Raijka G. Diagnostic features of atopic dermatitis. Acta Derm Venereal Suppl (Stockh) 1980;92:44-7.
21. Kunz B, Oranje A, Labreze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997;195(1):10-19.
22. Marley J, Baker CS, English J, eds. Getting to know your drugs. In: Therapeutic Guidelines: Dermatology. Version 2, 2004. North Melbourne, Australia: Therapeutic Guidelines, 2004:35.
23. Lawson V, Lewis-Jones MS, Finlay AY, et al. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol 1998;138(1):107-13.
24. Illi S, von Mutius E, Lau S, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004;113(5):925-31.
25. Murch SH. Toll of allergy reduced by probiotics. Lancet 2001;357(9262):1057-59.